These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101 [TBL] [Abstract][Full Text] [Related]
10. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts. Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S Elife; 2023 Dec; 12():. PubMed ID: 38078905 [TBL] [Abstract][Full Text] [Related]
11. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes. Savio-Galimberti E; Knollmann BC PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139 [TBL] [Abstract][Full Text] [Related]
12. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action. Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008 [TBL] [Abstract][Full Text] [Related]
13. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229 [TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death. Thomas NL; George CH; Lai FA Cardiovasc Res; 2004 Oct; 64(1):52-60. PubMed ID: 15364613 [TBL] [Abstract][Full Text] [Related]
16. A knock-in mouse model of N-terminal R420W mutation of cardiac ryanodine receptor exhibits arrhythmogenesis with abnormal calcium dynamics in cardiomyocytes. Okudaira N; Kuwahara M; Hirata Y; Oku Y; Nishio H Biochem Biophys Res Commun; 2014 Sep; 452(3):665-8. PubMed ID: 25193700 [TBL] [Abstract][Full Text] [Related]
17. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy. Kang G; Giovannone SF; Liu N; Liu FY; Zhang J; Priori SG; Fishman GI Circ Res; 2010 Aug; 107(4):512-9. PubMed ID: 20595652 [TBL] [Abstract][Full Text] [Related]
18. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880 [TBL] [Abstract][Full Text] [Related]
19. Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca Takenaka M; Kodama M; Murayama T; Ishigami-Yuasa M; Mori S; Ishida R; Suzuki J; Kanemaru K; Sugihara M; Iino M; Miura A; Nishio H; Morimoto S; Kagechika H; Sakurai T; Kurebayashi N Mol Pharmacol; 2023 Dec; 104(6):275-286. PubMed ID: 37678938 [TBL] [Abstract][Full Text] [Related]
20. Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors. Seidel M; Thomas NL; Williams AJ; Lai FA; Zissimopoulos S Cardiovasc Res; 2015 Jan; 105(1):118-28. PubMed ID: 25411383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]